We describe here the development of a new, non-isotopic immunological assay
termed CMIA (carbonyl metallo immunoassay) that uses metal carbonyl comple
xes as tracers and Fourier transform infrared spectroscopy (FT-IR) as the d
etection method. This assay is based on the particular spectral features of
these complexes, which show very strong absorption bands in the 1800-2200
cm(-1) spectral range where proteins and organic molecules do not absorb. I
n Section 1, the optimisation of the quantitative detection of these tracer
s is detailed. In Section 2, the implementation of mono-CMIA is described,
including the CMIA assays of three antiepileptic drugs (carbamazepine, phen
obarbital, phenytoin). Finally, extension to the simultaneous double- and t
riple-CMIA of these drugs is reported. (C) 1999 Elsevier Science B.V. All r
ights reserved.